A specific role of PRKCA in radiotherapy-elicited toxicities was highlighted by the study by Weigel et al., where protein and mRNA expression data indicated increased expression of PRKCA in fibroblasts of breast cancer patients developing radiation fibrosis [43]. The gene discussed is PRKCA; the disease is radiation pneumonitis.